Urologues et oncologues médicaux (Cancer de la prostate), Étude de recherche rémunérée

Mercor is conducting a paid research study in collaboration with a leading AI research lab focused on improving healthcare. We are seeking board-certified urologists and medical oncologists in the United States who manage patients with metastatic prostate cancer to take part in a short online survey about treatment decision-making.

Responsibilities

Participants will be asked to:

• Complete a structured ~30-minute online survey

• Share perspectives on how you evaluate and select systemic treatments for patients with prostate cancer

• Submit all responses within the given timeline

Requirements

• Urologist or medical oncologist with an MD or DO

• Board certified in your specialty

• Hold an active, unrestricted US medical license and practice primarily in the United States

• Spend at least 25% of your professional time in direct patient care

• Have cared for prostate-cancer patients in the past 12 months, including at least one patient with metastatic hormone-sensitive (mHSPC) or castration-resistant (mCRPC) prostate cancer

• Regularly manage metastatic prostate cancer, with primary or shared responsibility for selecting systemic treatment

• Able to independently complete a ~30-minute online survey

Please note: this study is not open to anyone who has taken part in prostate-cancer market research in the past 3 months, or who (or whose immediate family) works for a pharmaceutical, diagnostics, market research, or advertising company, a wholesaler, or a specialty pharmacy.

Engagement Details

• Format: Online survey

• Duration: Approximately 30 minutes

• Compensation: One-time payment upon successful verification of the submission

• Location: Remote (United States)

Why Participate

• Contribute to research shaping the next generation of healthcare AI tools

• Share your real-world clinical expertise in managing advanced prostate cancer